GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Average Rating of “Hold” from Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been given an average rating of “Hold” by the seventeen analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $80.6667.

A number of equities research analysts have recently issued reports on GEHC shares. Evercore set a $80.00 price objective on GE HealthCare Technologies in a report on Thursday, April 30th. Piper Sandler reduced their price objective on GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. The Goldman Sachs Group cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $81.00 to $65.00 in a report on Thursday, April 30th. Citigroup reduced their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a report on Thursday, April 30th. Finally, Mizuho reduced their price objective on GE HealthCare Technologies from $90.00 to $80.00 in a report on Thursday, April 30th.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $60.76 on Monday. The business’s 50 day moving average price is $69.58 and its two-hundred day moving average price is $76.72. The company has a market cap of $27.64 billion, a PE ratio of 14.54, a price-to-earnings-growth ratio of 1.37 and a beta of 0.74. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies has a twelve month low of $58.75 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the firm earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts predict that GE HealthCare Technologies will post 4.89 EPS for the current year.

Insider Activity at GE HealthCare Technologies

In related news, CEO Peter J. Arduini purchased 4,169 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The stock was acquired at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the purchase, the chief executive officer owned 259,424 shares in the company, valued at approximately $15,544,686.08. This represents a 1.63% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Rodney F. Hochman purchased 1,618 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was bought at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the purchase, the director owned 1,618 shares of the company’s stock, valued at $100,364.54. This trade represents a ∞ increase in their position. The SEC filing for this purchase provides additional information. Over the last quarter, insiders have purchased 11,847 shares of company stock valued at $719,555. Insiders own 0.36% of the company’s stock.

Institutional Investors Weigh In On GE HealthCare Technologies

Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in shares of GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after buying an additional 267,058 shares during the period. Auto Owners Insurance Co boosted its stake in shares of GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after buying an additional 33,629,559 shares during the period. Dodge & Cox boosted its stake in shares of GE HealthCare Technologies by 13.4% in the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after buying an additional 3,693,918 shares during the period. Capital Research Global Investors boosted its stake in shares of GE HealthCare Technologies by 1.6% in the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after buying an additional 389,796 shares during the period. Finally, State Street Corp boosted its stake in shares of GE HealthCare Technologies by 2.0% in the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after buying an additional 401,932 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.